Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CAMMA', Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.276
EU - Europa 4.638
AS - Asia 2.180
SA - Sud America 256
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 9
Totale 21.454
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.236
IT - Italia 1.521
CN - Cina 1.046
FI - Finlandia 866
SG - Singapore 774
UA - Ucraina 561
DE - Germania 462
IE - Irlanda 345
GB - Regno Unito 276
BR - Brasile 227
RU - Federazione Russa 153
SE - Svezia 125
RO - Romania 92
TR - Turchia 76
IN - India 66
FR - Francia 61
CI - Costa d'Avorio 55
HK - Hong Kong 40
KR - Corea 39
BE - Belgio 38
AT - Austria 32
NL - Olanda 26
CA - Canada 21
MY - Malesia 18
IR - Iran 16
UZ - Uzbekistan 16
CZ - Repubblica Ceca 15
CH - Svizzera 14
MX - Messico 14
IQ - Iraq 11
JP - Giappone 11
EU - Europa 9
ES - Italia 8
PL - Polonia 8
AU - Australia 7
AR - Argentina 6
BD - Bangladesh 6
CO - Colombia 6
GR - Grecia 6
JO - Giordania 6
PK - Pakistan 6
DZ - Algeria 5
LB - Libano 5
LT - Lituania 5
MA - Marocco 5
SA - Arabia Saudita 5
VN - Vietnam 5
BO - Bolivia 4
EG - Egitto 4
GE - Georgia 4
KE - Kenya 4
TN - Tunisia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CL - Cile 3
DK - Danimarca 3
EC - Ecuador 3
MM - Myanmar 3
NG - Nigeria 3
NO - Norvegia 3
OM - Oman 3
PH - Filippine 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
HU - Ungheria 2
IL - Israele 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GH - Ghana 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
PA - Panama 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 21.454
Salva come PNG Salva come JPEG
Città #
Fairfield 2.562
Ashburn 1.278
Woodbridge 1.235
Chandler 1.099
Houston 955
Seattle 952
Wilmington 935
Cambridge 825
Ann Arbor 671
Singapore 532
Palermo 433
Dublin 345
Jacksonville 305
Medford 304
Altamura 226
Des Moines 218
Nanjing 198
Princeton 188
Lawrence 173
San Diego 128
New York 108
Boardman 97
Dearborn 91
Beijing 88
Santa Clara 88
Tulsa 85
Jinan 76
Shenyang 74
Nanchang 66
London 56
Abidjan 55
Hebei 53
Milan 51
Izmir 50
Jiaxing 47
Ludwigshafen am Rhein 47
Changsha 45
Tianjin 44
Brussels 38
Saint Petersburg 38
Ningbo 37
Zhengzhou 37
Helsinki 33
Los Angeles 33
Kumar 32
Seongnam 30
Bremen 29
Nuremberg 28
Verona 28
Rome 27
Venice 27
Columbus 26
Guangzhou 26
Falls Church 25
Hangzhou 25
Hong Kong 25
San Paolo di Civitate 25
Council Bluffs 23
Taizhou 20
Phoenix 19
Pune 19
Auburn Hills 18
Orange 17
Lanzhou 16
Redwood City 16
Kilburn 15
Dallas 14
Düsseldorf 14
San Mateo 14
Vienna 14
West Jordan 14
Munich 12
Ottawa 12
Falkenstein 11
Haikou 11
Taiyuan 11
Washington 11
Chicago 10
Kunming 10
Moscow 10
Central 9
Hefei 9
Tashkent 9
Edinburgh 8
Indiana 8
Istanbul 8
Redmond 8
Rio de Janeiro 8
Shanghai 8
Tappahannock 8
Amsterdam 7
Brno 7
Fuzhou 7
Hounslow 7
Napoli 7
Tehran 7
Toronto 7
Aragona 6
Barcellona Pozzo di Gotto 6
Belo Horizonte 6
Totale 15.833
Salva come PNG Salva come JPEG
Nome #
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. 208
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease 206
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis 201
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. 199
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 195
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C. 191
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 184
Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response 179
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease 178
Inflammation and Aortic Stiffness: An Individual Participant Data Meta-Analysis in Patients With Inflammatory Bowel Disease. 174
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. 173
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C 173
Treatment of hepatocellular carcinoma: present and future. 171
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C 168
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. 164
The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature data. 161
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis 161
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. 159
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease 158
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems 156
751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS 155
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease 155
Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation 154
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 154
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women 153
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease 152
Causes of and prevention strategies for hepatocellular carcinoma. 150
Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection 150
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. 148
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C 147
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. 145
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension 145
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C 144
Clinical implications of the hyperdynamic syndrome in cirrhosis. 144
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 144
Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C 143
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort 143
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study 142
Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection. 142
Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients 141
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 141
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. 140
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease 139
Transjugular Intrahepatic Portosystemic Shunt For Refractory Ascites: A Meta-Analysis Of Individual Patient Data 137
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. 137
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 137
High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C 136
Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis 135
Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years 135
Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis. 134
Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing 134
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 134
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. 133
THE COMPLEX INTERPLAY BETWEEN VITAMIN D DEFICIENCY AND DIABETES 132
Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data 132
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data 131
Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in post-operative Crohn's disease 131
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. 131
Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C 131
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values 131
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C 130
Assessment of treatment response in hepatocellular carcinoma: a review of literature 130
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 130
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies 130
Hyperferritinemia is a risk factor for steatosis in chronic liver disease. 130
Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial 129
Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy 129
Treatment of hepatitis C: critical appraisal of the evidence 129
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study 129
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. results from a prospective study 129
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 127
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity 127
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis 126
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 126
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C 126
When and how to treat acute hepatitis C? 126
Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C 125
Reproductive status is associated with the severity of fibrosis in women with hepatitis C 125
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease 125
The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases 125
The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach 124
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy 124
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. 124
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study 124
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 124
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis 124
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease 124
Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD 124
Prevention of hepatocellular carcinoma 123
Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. 122
CT enterography as a powerful tool for the evaluation of inflammatory activity in Crohn's disease: relationship of CT findings with CDAI and acute-phase reactants 122
Treating patients with HCV genotype 1 and low viraemia: more than meets the eye 121
Unsatisfactory quality of hepatological information on the internet 121
Mortality in patients with hepatocellular carcinoma predicted by six scoring: none is the winner 120
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. 120
Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model 119
Insulin resistance is associated with steatosis in non-diabetic patients with genotype 1 chronic hepatitis C 119
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use 119
Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study 118
Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation - authors' reply 117
Totale 14.187
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.031 0 0 0 0 0 0 0 0 0 315 545 171
2020/20213.065 184 258 185 297 261 164 192 237 342 395 259 291
2021/20222.423 178 522 62 68 66 98 137 142 297 249 189 415
2022/20233.136 338 663 44 352 306 484 176 211 382 17 110 53
2023/20241.197 52 205 67 88 89 300 115 59 22 31 28 141
2024/20252.065 76 186 296 348 114 163 229 207 280 166 0 0
Totale 22.375